Clozapine: Drug Safety Communication – FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program

Audience: Psychiatry, Pharmacy, Hematology ISSUE: FDA is making changes to the requirements for monitoring, prescribing, dispensing, and receiving the schizophrenia medicine clozapine, to address continuing safety concerns and current knowledge…